Factors regulating isoprostane formation in vivo

Antioxidants and Redox Signaling

Volumn 7, Issue 1-2, 2005, Pages 221-235

  Basu, Samar ^a   Helmersson, Johanna ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ARACHIDONIC ACID; BEZAFIBRATE; CERIVASTATIN; ESTROGEN; FENOFIBRATE; FREE RADICAL; GESTAGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IBUPROFEN; INDOBUFEN; INDOMETACIN; ISOPROSTANE; NONSTEROID ANTIINFLAMMATORY AGENT; OXYGEN; PRAVASTATIN; PROSTAGLANDIN F2 ALPHA; ROFECOXIB; SIMVASTATIN;

ALCOHOL CONSUMPTION; ATHEROSCLEROSIS; DIABETES MELLITUS; DIET SUPPLEMENTATION; DRUG USE; FAT INTAKE; HUMAN; INFLAMMATION; LIPID PEROXIDATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; REGULATORY MECHANISM; REPERFUSION INJURY; REVIEW; SEPTIC SHOCK; SMOKING;

AGED; ANIMALS; ARACHIDONIC ACID; ARTERIOSCLEROSIS; ASCORBIC ACID; CARDIOVASCULAR DISEASES; DISEASE MODELS, ANIMAL; FATTY ACIDS; FEMALE; FREE RADICALS; HUMANS; ISOPROSTANES; LIPID PEROXIDATION; MALE; MODELS, CHEMICAL; OXIDANTS; OXIDATIVE STRESS; OXYGEN; REPERFUSION INJURY; RISK FACTORS; TIME FACTORS; VITAMIN E;

EID: 13244259144     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2005.7.221     Document Type: Review

References (134)

1. Ambring A, Friberg P, Axelsen M, Laffrenzen M, Taskinen MR, Basu S, and Johansson M, Effects of Mediterranean-inspired diet on blood lipids, vascular function and oxidative stress in healthy subjects. Clin Sci (Lond) 106: 519-525, 2004.
2. Änggård E, Larsson C, and Samuelsson B. The distribution of 15-hydroxy prostaglandin dehydrogenase and prostaglandin-delta 13-reductase in tissues of the swine. Acta Physiol Scand 81: 396-404, 1971.
3. Bachi A, Zuccato E, Baraldi M, Fanelli R, and Chiabrando C. Measurement of urinary 8-epi-prostaglandin F2alpha, a novel index of lipid peroxidation in vivo, by immunoaffinity extraction/gas chromatography-mass spectrometry. Basal levels in smokers and nonsmokers. Free Radic Biol Med 20: 619-624, 1996.
4. Basu S. Metabolism of 8-iso-PGF2alpha in the rabbits. Prostaglandins Leukot Essent Fatty Acids 57: 276, 1997.
5. Basu S. Radioimmunoassay of 8-iso-prostaglandin F2alpha: an index for oxidative injury via free radical catalysed lipid peroxidation. Prostaglandins Leukot Essent Fatty Acids 58: 319-325, 1998.
6. Basu S. Metabolism of 8-iso-prostaglandin F2alpha. FEBS Lett 428: 32-36, 1998.
7. Basu S. Oxidative injury induced cyclooxygenase activation in experimental hepatotoxicity. Biochem Biophys Res Commun 254: 764-761, 1999.
8. Basu S. Isoprostanes: novel bioactive products of lipid peroxidation. Free Radic Res 38: 105-122, 2004.
9. Basu S and Eriksson M. Oxidative injury and survival during endotoxemia. FEBS Lett 438: 159-160, 1998.
10. Basu S and Eriksson M. Lipid peroxidation induced by an early inflammatory response in endotoxaemia. Acta Anaesthesiol Scand 44: 17-23, 2000.
11. Basu S and Eriksson M. Vitamin E in relation to lipid peroxidation in experimental septic shock. Prostaglandins Leukot Essent Fatty Acids 62: 195-199, 2000.
12. Basu S and Stjernschantz J. Delta 13-reductase dependent metabolism of prostaglandins in the mammalian brain and eye. Prostaglandins Leukot Essent Fatty Acids 57: 305-310, 1997.
13. Basu S, Sjöquist B, Resul B, and Stjernschantz J. Presence of a 15-ketoprostaglandin delta 13-reductase in porcine cornea. Acta Chem Scand 46: 108-110, 1992.
14. Basu S, Nozari A, Liu XL, Rubertsson S, and Wiklund L. Development of a novel biomarker of free radical damage in reperfusion injury after cardiac arrest. FEBS Lett 470: 1-6, 2000.
15. Basu S, Riserus U, Turpeinen A, and Vessby B. Conjugated linoleic acid induces lipid peroxidation in men with abdominal obesity. Clin Sci 99: 511-516, 2000.
16. Basu S, Smedman A, and Vessby B. Conjugated linoleic acid induces lipid peroxidation in humans. FEBS Lett 468: 33-36, 2000.
17. Basu S, Hellberg A, Ulus AT, Westman J, and Karacagil S. Biomarkers of free radical injury during spinal cord ischemia. FEBS Lett 508: 36-38, 2001.
18. Basu S, Mutschler DK, Larsson AO, Kiiski R, Nordgren A, and Eriksson MB. Propofol (Diprivan-EDTA) counteracts oxidative injury and deterioration of the arterial oxygen tension during experimental septic shock. Resuscitation 50: 341-348, 2001.
19. Basu S, Hayashi M, Ritsuko N, Kobayashi K, Takeda S, and Ishihara O. Levels of lipid peroxidation products and anti-oxidants in preeclampsia and normal pregnancy. Abstract. Free Radic Biol Med 33: S409, 2002.
20. Basu S, Liu X, Nozari A, Rubertsson S, Miclescu A, and Wiklund L. Evidence for time-dependent maximum increase of free radical damage and eicosanoid formation in the brain as related to duration of cardiac arrest and cardio-pulmonary resuscitation. Free Radic Res 37: 251-256, 2003.
21. Berg K, Wiseth R, Bjerve K, Brurok H, Gunnes S, Skarra S, Jynge P, and Basu S. Oxidative stress and myocardial damage during elective percutaneous coronary interventions and coronary angiography. A comparison of blood-borne isoprostane and troponin release. Free Radic Res 38:517-525, 2004.
22. Block G, Dietrich M, Norkus EP, Morrow JD, Hudes M, Caan B, and Packer L. Factors associated with oxidative stress in human populations. Am J Epidemiol 156: 274-285, 2002.
23. Camphausen K, Ménard C, Sproull M, Goley E, Basu S, and Coleman C. Isoprostane levels in the urine of patients with prostate cancer receiving radiotherapy are not elevated. Int J Radiat Oncol Biol Phys, 58: 1536-1539, 2004.
24. Catella F, Reilly MP, Delanty N, Lawson JA, Moran N, Meagher E, and FitzGerald GA. Physiological formation of 8-epi-PGF2 alpha in vivo is not affected by cyclooxygenase inhibition. Adv Prostaglandin Thromboxane Leukot Res 23: 233-236, 1995.
25. Chehne F, Oguogho A, Lupattelli G, Palumbo B, and Sinzinger H, Effect of giving up cigarette smoking and restarting in patients with clinically manifested atherosclerosis. Prostaglandins Leukot Essent Fatty Acids 67; 333-339, 2002.
26. Chiabrando C, Valagussa A, Rivalta C, Durand T, Guy A, Zuccato E, Villa P, Rossi JC, and Fanelli R, Identification and measurement of endogenous beta-oxidation metabolites of 8-epi-prostaglandin F2alpha. J Biol Chem 274: 1313-1319, 1999.
27. Childs A, Jacobs C, Kaminski T, Halliwell B, and Leeuwenburgh C. Supplementation with vitamin C and W-acetyl-cysteine increases oxidative stress in humans after an acute muscle injury induced by eccentric exercise. Free Radic Biol Med 31: 745-753, 2001.
28. Chowienczyk PJ, Brett SE, Gopaul NK, Meeking D, Marchetti M, Russell-Jones DL, Änggård EE, and Ritter JM. Oral treatment with an antioxidant (raxofelast) reduces oxidative stress and improves endothelial function in men with type II diabetes. Diabetologia 43: 974-977, 2000.
29. Clarke R, Harrison G, and Richards S. Effect of vitamins and aspirin on markers of platelet activation, oxidative stress and homocysteine in people at high risk of dementia. J Intern Med 254: 67-75, 2003.
30. Cracowski JL, Durand T, and Bessard G. Isoprostanes as a biomarker of lipid peroxidation in humans: physiology, pharmacology and clinical implications. Trends Pharmacol Sci 23: 360-366, 2002.
31. Cracowski JL, Stanke-Labesque F, and Bessard G. Physiological variations of isoprostanes: a step forward? Arterioscler Thromb Vasc Biol 22: 1239-1241, 2002.
32. Cracowski JL, Baguet JP, Ormezzano O, Bessard J, Stanke-Labesque F, Bessard G, and Mallion JM. Lipid peroxidation is not increased in patients with untreated mild-to-moderate hypertension. Hypertension 41: 286-288, 2003.
33. Darko D, Dornhorst A, Kelly FJ, Ritter JM, and Chowienczyk PJ. Lack of effect of oral vitamin C on blood pressure, oxidative stress and endothelial function in type 11 diabetes. Clin Sci (Lond) 103: 339-344, 2002.
34. Davi G, Alessandrini P, Mezzetti A, Minotti G, Bucciarelli T, Costantini F, Cipollone F, Bon GB, Ciabattoni G, and Patrono C. In vivo formation of 8-epi-prostaglandin F2 alpha is increased in hypercholesterolemia. Arterioscler Thromb Vasc Biol 17: 3230-3235, 1997.
35. Davi G, Ciabattoni G, Consoli A, Mezzetti A, Falco A, Santarone S, Pennese E, Vitacolonna E, Bucciarelli T, Costantini F, Capani F, and Patrono C. In vivo formation of 8-iso-prostaglandin F2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. Circulation 99: 224-229, 1999.
36. Davi G, Di Minno G, Coppola A, Andria G, Cerbone AM, Madonna P, Tufano A, Falco A, Marchesani P, Ciabattoni G, and Patrono C. Oxidative stress and platelet activation in homozygous homocystinuria. Circulation 104: 1124-1128, 2001.
37. Davi G, Guagnano MT, Ciabattoni G, Basili S, Falco A, Marinopiccoli M, Nutini M, Sensi S, and Patrono C. Platelet activation in obese women: role of inflammation and oxidant stress. JAMA 288: 2008-2014, 2002.
38. Davi G, Chiarelli F, Santilli F, Pomilio M, Vigneri S, Falco A, Basili S, Ciabattoni G, and Patrono C. Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration. Circulation 107: 3199-3203, 2003.
39. De Caterina R, Cipollone F, Filardo FP, Zimarino M, Bernini W, Lazzerini G, Bucciarelli T, Falco A, Marchesani P, Muraro R, Mezzetti A, and Ciabattoni G. Low-density lipoprotein level reduction by the 3-hydroxy-3-methylglutaryl coenzyme-A inhibitor simvastatin is accompanied by a related reduction of F2-isoprostane formation in hypercholesterolemic subjects: no further effect of vitamin E. Circulation 106: 2543-2549, 2002.
40. De Cristofaro R, Rocca B, Vitacolonna E, Falco A, Marchesani P, Ciabattoni G, Landolfi R, Patrono C, and Davi G. Lipid and protein oxidation contribute to a prothrombotic state in patients with type 2 diabetes mellitus. J Thromb Haemost 1: 250-256, 2003.
41. Delanty N, Reilly MP, Pratico D, Lawson JA, McCarthy JF, Wood AE, Ohnishi ST, Fitzgerald DJ, and FitzGerald GA. 8-epi PGF2 alpha generation during coronary reperfusion. A potential quantitative marker of oxidant stress in vivo. Circulation 95: 2492-2499, 1997.
42. Desideri G, Croce G, Tucci M, Passacquale G, Broccoletti S, Valeri L, Santucci A, and Ferri C. Effects of bezafibrate and simvastatin on endothelial activation and lipid peroxidation in hypercholesterolemia: evidence of different vascular protection by different lipid-lowering treatments. J Clin Endocrinol Metab 88: 5341-5347, 2003.
43. Dietrich M, Block G, Hudes M, Morrow JD, Norkus EP, Traber MG, Cross CE, and Packer L. Antioxidant supplementation decreases lipid peroxidation biomarker F(2)-isoprostanes in plasma of smokers. Cancer Epidemiol Biomarkers Prev 11: 7-13, 2002.
44. Dillon SA, Lowe GM, Billington D, and Rahman K. Dietary supplementation with aged garlic extract reduces plasma and urine concentrations of 8-iso-prostaglandin F(2 alpha) in smoking and nonsmoking men and women. J Nutr 132: 168-171, 2002.
45. Dragsted LO, Pedersen A, Hermetter A, Basu S, Hansen M, Ravn-Haren G, Kail M, Breinholt V, Castenmiller J, Stagsted J, Jakobsen J, Skibsted LH, Rasmussen SE, Loft S, and Sandström B. The 6-a-day study: effects of fruit and vegetables on markers of oxidative stress and defense in healthy nonsmokers. Am J Clin Nutr 79: 1060-1072, 2004.
46. Feillet-Coudray C, Tourtauchaux R, Niculescu M, Rock E, Tauveron I, Alexandre-Gouabau MC, Rayssiguier Y, Jalenques I, and Mazur A. Plasma levels of 8-epiPGF2alpha, an in vivo marker of oxidative stress, are not affected by aging or Alzheimer's disease. Free Radic Biol Med 27: 463-469, 1999.
47. Freese R, Basu S, and Mutanen M. Green tea extract does not affect urinary markers of lipid peroxidation or thromboxane or nitric oxide synthesis during a high-linoleic acid diet in healthy females. Lipids 34: S317, 1999.
48. Freese R, Alfthan G, Jauhiainen M, Basu S, Erlund I, Salminen I, Aro A, and Mutanen M. High intakes of vegetables, berries, and apples combined with a high intake of linoleic or oleic acid only slightly affect markers of lipid peroxidation and lipoprotein metabolism in healthy subjects. Am J Clin Nutr 76: 950-960, 2002.
49. Gopaul NK, Änggård EE, Mallet AI, Betteridge DJ, Wolff SP, and Nourooz-Zadeh J. Plasma 8-epi-PGF2 alpha levels are elevated in individuals with non-insulin dependent diabetes mellitus. FEBS Lett 368: 225-229, 1995.
50. Gopaul NK, Halliwell B, and Änggård EE. Measurement of plasma F2-isoprostanes as an index of lipid peroxidation does not appear to be confounded by diet. Free Radic Res 33: 115-127, 2000.
51. Gopaul NK, Zacharowski K, Halliwell B, and Änggård EE. Evaluation of the postprandial effects of a fast-food meal on human plasma F(2)-isoprostane levels. Free Radic Biol Med 28: 806-814, 2000.
52. Gopaul NK, Manraj MD, Hebe A, Lee Kwai Van S, Johnston A, Carrier MJ, and Änggård EE. Oxidative stress could precede endothelial dysfunction and insulin resistance in Indian Mauritians with impaired glucose metabolism. Diabetologia 44: 706-712, 2001.
53. Helmersson J and Basu S. F2-isoprostane excretion rate and diurnal variation in human urine. Prostaglandins Leukot Essent Fatty Acids 61: 203-205, 1999.
54. Helmersson J and Basu S. F(2)-isoprostane and prostaglandin F(2 alpha)metabolite excretion rate and day to day variation in healthy humans. Prostaglandins Leukot Essent Fatty Acids 65: 99-102, 2001.
55. Helmersson J, Mattsson P, and Basu S. Prostaglandin F2alpha metabolite and F2-isoprostane excretion rates in migraine. Clin Sci (Lond) 102: 39-43, 2002.
56. Helmersson J, Vessby B, Larsson A, and Basu S. Association of type 2 diabetes with cyclooxygenase-mediated inflammation and oxidative stress in an elderly population. Circulation 109: 1729-1734, 2004.
57. Higdon JV, Liu J, Du SH, Morrow JD, Ames BN, and Wander RC. Supplementation of postmenopausal women with fish oil rich in eicosapentaenoic acid and docosahexaenoic acid is not associated with greater in vivo lipid peroxidation compared with oils rich in oleate and linoleate as assessed by plasma malondialdehyde and F(2)-isoprostanes. Am J Clin Nutr 72: 714-722, 2000.
58. Hodgson JM, Croft KD, Mori TA, Burke V, Beilin LJ, and Puddey IB. Regular ingestion of tea does not inhibit in vivo lipid peroxidation in humans. J Nutr 132: 55-58, 2002.
59. Hodgson JM, Watts GF, Playford DA, Burke V, and Croft KD. Coenzyme Q10 improves blood pressure and glycaemic control: a controlled trial in subjects with type 2 diabetes. Eur J Clin Nutr 56: 1137-1142, 2002.
60. Hoeldtke RD, Bryner KD, McNeill DR, Warehime SS, Van Dyke K, and Hobbs G. Oxidative stress and insulin requirements in patients with recent-onset type 1 diabetes. J Clin Endocrinol Metab 88: 1624-1628, 2003.
61. Ide T, Tsutsui H, Ohashi N, Hayashidani S, Suematsu N, Tsuchihashi M, Tamai H, and Takeshita A. Greater oxidative stress in healthy young men compared with premenopausal women. Arterioscler Thromb Vasc Biol 22: 438-442, 2002.
62. Jacob RA, Aiello GM, Stephensen CB, Blumberg JB, Milbury PE, Wallock LM, and Ames BN. Moderate antioxidant supplementation has no effect on biomarkers of oxidant damage in healthy men with low fruit and vegetable intakes. J Nutr 133: 740-743, 2003.
63. Jang Y, Lee JH, Kim OY, Park HY, and Lee SY. Consumption of whole grain and legume powder reduces insulin demand, lipid peroxidation, and plasma homocysteine concentrations in patients with coronary artery disease: randomized controlled clinical trial. Arterioscler Thromb Vasc Biol 21: 2065-2071, 2001.
64. Janssen LJ. Isoprostanes: an overview and putative roles in pulmonary pathophysiology. Am J Physiol Lung Cell Mol Physiol 280: L1067-L1082, 2001.
65. Kaikkonen J, Porkkala-Sarataho E, Morrow JD, Roberts LJ 2nd, Nyyssonen K, Salonen R, Tuomainen TP, Ristonmaa U, Poulsen HE, and Salonen JT. Supplementation with vitamin E but not with vitamin C lowers lipid peroxidation in vivo in mildly hypercholesterolemic men. Free Radic Res 35: 967-978, 2001.
66. Kaminski KA, Bonda TA, Korecki J, and Musial WJ. Oxidative stress and neutrophil activation-the two keystones of ischemia/reperfusion injury. Int J Cardiol 86: 41-59, 2002.
67. Kauffman LD, Sokol RJ, Jones RH, Awad JA, Rewers MJ, and Norris JM. Urinary F2-isoprostanes in young healthy children at risk for type 1 diabetes mellitus. Free Radic Biol Med 35: 551-557, 2003.
68. Ke RW, Todd Pace D, and Ahokas RA. Effect of short-term hormone therapy on oxidative stress and endothelial function in African American and Caucasian post-menopausal women. Fertil Steril 79: 1118-1122, 2003.
69. Keaney JF Jr, Larson MG, Vasan RS, Wilson PW, Lipinska I, Corey D, Massaro JM, Sutherland P, Vita JA, and Benjamin EJ. Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol 23: 434-439, 2003.
70. Kijima Y, Hashimura K, Matsu-ura Y, Kato Y, Yasuda T, Ueda T, Orita Y, and Fukunaga M. Transcardiac 8-isoprostaglandin F(2 alpha)generation from acute myocardial infarction heart: insight into abrupt reperfusion and oxidant stress. Prostaglandins Leukot Essent Fatty Acids 64: 161-166, 2001.
71. Lee TM, Chou TF, and Tsai CH. Association of pravastatin and left ventricular mass in hypercholesterolemic patients: role of 8-iso-prostaglandin F2alpha formation. J Cardiovasc Pharmacol 40: 868-874, 2002.
72. Levine M, Wang Y, Padayatty SJ, and Morrow J. A new recommended dietary allowance of vitamin C for healthy young women. Proc Natl Acad Sci U S A 98: 9842-9846, 2001.
73. Li H, Lawson JA, Rokach J, Adiyaman M, Hwang SW, Khanapure SP, and FitzGerald GA. Identification of two major F2 isoprostanes, 8, 12-iso- and 5-epi-8, 12-iso-isoprostane F2alpha-V1, in human urine. J Biol Chem 273: 29295-29301, 1998.
74. Liu XL, Nozari A, Basu S, Ronquist G, Rubertsson S, and Wiklund L. Neurological outcome after experimental cardiopulmonary resuscitation: a result of delayed and potentially treatable neuronal injury? Acta Anaesthesiol Scand 46: 537-546, 2002.
75. Liu XL, Wiklund L, Nozari A, Rubertsson S, and Basu S. Differences in cerebral reperfusion and oxidative injury after cardiac arrest in pigs. Acta Anaesthesiol Scand 47: 958-967, 2003.
76. Lopes HF, Martin KL, Nashar K, Morrow JD, Goodfriend TL, and Egan BM. DASH diet lowers blood pressure and lipid-induced oxidative stress in obesity. Hypertension 41:422-430, 2003.
77. Lopes HF, Morrow JD, Stoijiljkovic MP, Goodfriend TL, and Egan BM. Acute hyperlipidemia increases oxidative stress more in African Americans than in white Americans. Am J Hypertens 16: 331-336, 2003.
78. Mastaloudis A, Leonard SW, and Traber MG. Oxidative stress in athletes during extreme endurance exercise. Free Radic Biol Med 31:911-922, 2001.
79. McCord JM. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 312: 159-163, 1985.
80. McCord JM. Oxygen-derived radicals: a link between reperfusion injury and inflammation. Fed Proc 46: 2402-2406, 1987.
81. Meagher EA, Barry OP, Burke A, Lucey MR, Lawson JA, Rokach J, and FitzGerald GA. Alcohol-induced generation of lipid peroxidation products in humans. J Clin Invest 104: 805-813, 1999.
82. Meagher EA, Barry OP, Lawson JA, Rokach J, and FitzGerald GA. Effects of vitamin E on lipid peroxidation in healthy persons. JAMA 285: 1178-1182, 2001.
83. Meghdadi S, Rodrigues M, Oguogho A, Santler R, and Sinzinger H. 8-Epi-PGF2alpha and 6-oxo-PGF1alpha in human (varicose) veins: influence of age, sex, and risk factors. Angiology 54: 317-324, 2003.
84. Minuz P, Patrignani P, Gaino S, Degan M, Menapace L, Tommasoli R, Seta F, Capone ML, Tacconelli S, Palatresi S, Bencini C, Del Vecchio C, Mansueto G, Arosio E, Santonastaso CL, Lechi A, Morganti A, and Patrono C. Increased oxidative stress and platelet activation in patients with hypertension and renovascular disease. Circulation 106: 2800-2805, 2002.
85. Montuschi P, Collins JV, Ciabattoni G, Lazzeri N, Corradi M, Kharitonov SA, and Barnes PJ. Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers. Am J Respir Crit Care Med 162: 1175-1177, 2000.
86. Mori TA, Dunstan DW, Burke V, Croft KD, Rivera JH, Beilin LJ, and Puddey IB. Effect of dietary fish and exercise training on urinary F2-isoprostane excretion in non-insulin-dependent diabetic patients. Metabolism 48: 1402-1408, 1999.
87. Mori TA, Puddey IB, Burke V, Croft KD, Dunstan DW, Rivera JH, and Beilin LJ. Effect of omega 3 fatty acids on oxidative stress in humans: GC-MS measurement of urinary F2-isoprostane excretion. Redox Rep 5: 45-46, 2000.
88. Mori TA, Woodman RJ, Burke V, Puddey IB, Croft KD, and Beilin LJ. Effect of eicosapentaenoic acid and docosahexaenoic acid on oxidative stress and inflammatory markers in treated-hypertensive type 2 diabetic subjects. Free Radic Biol Med 35: 772-781, 2003.
89. Morris JM, Gopaul NK, Endresen MJ, Knight M, Linton EA, Dhir S, Änggård EE, and Redman CW. Circulating markers of oxidative stress are raised in normal pregnancy and pre-eclampsia. Br J Obstet Gynaecol 105: 1195-1199, 1998.
90. Morrow JD and Roberts LJ 2nd. The isoprostanes. Current knowledge and directions for future research. Biochem Pharmacol 51: 1-9, 1996.
91. Morrow JD, Hill KE, Burk RF, Nammour TM, Badr KF, and Roberts LJ 2nd. A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci USA 87: 9383-9387, 1990.
92. Morrow JD, Awad JA, Boss HJ, Blair IA, and Roberts LJ 2nd. Non-cyclooxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids. Proc Natl Acad Sci USA 89: 10721-10725, 1992.
93. Morrow JD, Awad JA, Kato T, Takahashi K, Badr KF, Roberts LJ 2nd, and Burk RF. Formation of novel non-cyclooxygenase-derived prostanoids (F2-isoprostanes) in carbon tetrachloride hepatotoxicity. An animal model of lipid peroxidation. J Clin Invest 90: 2502-2507, 1992.
94. Morrow JD, Frei B, Longmire AW, Gaziano JM, Lynch SM, Shyr Y, Strauss WE, Gates JA, and Roberts LJ 2nd. Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. N Engl J Med 332: 1198-1203, 1995.
95. Murphey LJ, Morrow JD, Sawathiparnich P, Williams GH, Vaughan DE, and Brown NJ. Acute angiotensin II increases plasma F2-isoprostanes in salt-replete human hypertensives. Free Radic Biol Med 35:711-718, 2003.
96. Mustad VA, Smith CA, Ruey PP, Edens NK, and DeMichele SJ. Supplementation with 3 compositionally different tocotrienol supplements does not improve cardiovascular disease risk factors in men and women with hypercholesterolemia. Am J Clin Nutr 76: 1237-1243, 2002.
97. Nälsén C, Basu S, Gustafsson IB, and Vessby B. Effects of a change of dietary fat quality on lipid peroxidation and antioxidants. Abstract. Annual Meeting of the Oxygen Club of California, Oxidants and Antioxidants in Biology. Santa Barbara, CA, USA, 1999.
98. Nieman DC, Henson DA, McAnulty SR, McAnulty L, Swick NS, Utter AC, Vinci DM, Opiela SJ, and Morrow JD. Influence of vitamin C supplementation on oxidative and immune changes after an ultramarathon. J Appl Physiol 92: 1970-1977, 2002.
99. Nourooz-Zadeh J, Smith CC, and Betteridge DJ. Measures of oxidative stress in heterozygous familial hypercholesterolaemia. Atherosclerosis 156: 435-441, 2001.
100. Obwegeser R, Oguogho A, Ulm M, Berghammer P, and Sinzinger H. Maternal cigarette smoking increases F2-isoprostanes and reduces prostacyclin and nitric oxide in umbilical vessels. Prostaglandins Other Lipid Mediat 57: 269-279, 1999.
101. O'Reilly JD, Mallet AI, McAnlis GT, Young IS, Halliwell B, Sanders TA, and Wiseman H. Consumption of flavonoids in onions and black tea: lack of effect on F2-isoprostanes and autoantibodies to oxidized LDL in healthy humans. Am J Clin Nutr 73: 1040-1044, 2001.
102. Patrignani P, Panara MR, Tacconelli S, Seta F, Bucciarelli T, Ciabattoni G, Alessandrini P, Mezzetti A, Santini G, Sciulli MG, Cipollone F, Davi G, Gallina P, Bon GB, and Patrono C. Effects of vitamin E supplementation on F(2)-isoprostane and thromboxane biosynthesis in healthy cigarette smokers. Circulation 102: 539-545, 2000.
103. Reilly M, Delanty N, Lawson JA, and FitzGerald GA. Modulation of oxidant stress in vivo in chronic cigarette smokers. Circulation 94: 19-25, 1996.
104. Reilly MP, Delanty N, Roy L, Rokach J, Callaghan PO, Crean P, Lawson JA, and FitzGerald GA. Increased formation of the isoprostanes IPF2alpha-1 and 8-epi-prostaglandin F2alpha in acute coronary angioplasty: evidence for oxidant stress during coronary reperfusion in humans. Circulation 96: 3314-3320, 1997.
105. Reilly MP, Pratico D, Delanty N, DiMinno G, Tremoli E, Rader D, Kapoor S, Rokach J, Lawson J, and FitzGerald GA. Increased formation of distinct F2 isoprostanes in hypercholesterolemia. Circulation 98: 2822-2828, 1998.
106. Richelle M, Turini ME, Guidoux R, Tavazzi I, Metairon S, and Fay LB. Urinary isoprostane excretion is not confounded by the lipid content of the diet. FEBS Lett 459: 259-262, 1999.
107. Riserus U, Basu S, Jovinge S, Fredrikson GN, Ärnlöv J, and Vessby B. Supplementation with conjugated linoleic acid causes isomer-dependent oxidative stress and elevated C-reactive protein: a potential link to fatty acid-induced insulin resistance. Circulation 106: 1925-1929, 2002.
108. Roberts CK, Vaziri ND, and Barnard RJ. Effect of diet and exercise intervention on blood pressure, insulin, oxidative stress, and nitric oxide availability. Circulation 106: 2530-2532, 2002.
109. Roberts LJ and Morrow JD. Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo. Free Radic Biol Med 28: 505-501, 2000.
110. Roberts LJ, Gates JA, Fazio S, Gross M, Linton M, and Morrow J. A-tocopherol supplementation reduces plasma F2-isoprostane concentrations in hypercholesterolemic humans only at doses of 800 IU or higher. Abstract. Free Radic Biol Med 33: S412, 2002.
111. Roberts LJ 2nd, Moore KP, Zackert WE, Oates JA, and Morrow JD. Identification of the major urinary metabolite of the F2-isoprostane 8-iso-prostaglandin F2alpha in humans. J Biol Chem 271: 20617-20620, 1996.
112. Sacheck JM, Milbury PE, Cannon JG, Roubenoff R, and Blumberg JB. Effect of vitamin E and eccentric exercise on selected biomarkers of oxidative stress in young and elderly men. Free Radic Biol Med 34: 1575-1588, 2003.
113. Salonen RM, Nyyssonen K, Kaikkonen J, Porkkala-Sarataho E, Voutilainen S, Rissanen TH, Tuomainen TP, Valkonen VP, Ristonmaa U, Lakka HM, Vanharanta M, Salonen JT, and Poulsen HE. Six-year effect of combined vitamin C and E supplementation on atherosclerotic progression: the Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) Study. Circulation 107: 947-953, 2003.
114. Sampson MJ, Gopaul N, Davies IR, Hughes DA, and Carrier MJ. Plasma F2 isoprostanes: direct evidence of increased free radical damage during acute hyperglycemia in type 2 diabetes. Diabetes Care 25: 537-541, 2002.
115. Sanchez-Moreno C, Cano MP, de Ancos B, Plaza L, Olmedilla B, Granado F, and Martin A. High-pressurized orange juice consumption affects plasma vitamin C, antioxidative status and inflammatory markers in healthy humans. J Nutr 133: 2204-2209, 2003.
116. Sinzinger H, Oguogho A, and Pilz H. Increased isoprostanes in children of smoking parents. Adv Exp Med Biol 525: 213-215, 2003.
117. Smedman A, Vessby B, and Basu S. Isomer-specific effects of conjugated linoleic acid on lipid peroxidation in humans: regulation by alpha-tocopherol and cyclo-oxygenase-2 inhibitor. Clin Sci (Lond) 106: 67-73, 2004.
118. Södergren E, Vessby B, and Basu S. Radioimmunological measurement of F(2)-isoprostanes after hydrolysis of lipids in tissues. Prostaglandins Leukot Essent Fatty Acids 63: 149-152, 2000.
119. Södergren E, Cederberg J, Vessby B, and Basu S. Vitamin E reduces lipid peroxidation in experimental hepatotoxicity in rats. Eur J Nutr 40: 10-16, 2001.
120. Södergren E, Gustafsson IB, Basu S, Nourooz-Zadeh J, Nälsén C, Turpeinen A, Berglund L, and Vessby B. A diet containing rapeseed oil-based fats does not increase lipid peroxidation in humans when compared to a diet rich in saturated fatty acids. Eur J Clin Nutr 55: 922-931, 2001.
121. Steensberg A, Morrow J, Toft AD, Bruunsgaard H, and Pedersen BK. Prolonged exercise, lymphocyte apoptosis and F2-isoprostanes. Eur J Appl Physiol 87: 38-42, 2002.
122. Stein TP and Leskiw MJ. Oxidant damage during and after spaceflight. Am J Physiol Endocrinol Metab 278: E375-E382, 2000.
123. Tsunekawa T, Hayashi T, Kano H, Sumi D, Matsui-Hirai H, Thakur NK, Egashira K, and Iguchi A. Cerivastatin, a hydroxymethylglutaryl coenzyme A reductase inhibitor, improves endothelial function in elderly diabetic patients within 3 days. Circulation 104: 376-379, 2001.
124. Turpeinen AM, Basu S, and Mutanen M. A high linoleic acid diet increases oxidative stress in vivo and affects nitric oxide metabolism in humans. Prostaglandins Leukot Essent Fatty Acids 59: 229-233, 1998.
125. Turpeinen AM, Mutanen M, Aro A, Salminen I, Basu S, Palmquist DL, and Griinari JM. Bioconversion of vaccenic acid to conjugated linoleic acid in humans. Am J Clin Nutr 76: 504-510, 2002.
126. Ulus AT, Aksoyek A, Ozkan M, Katircioglu SF, and Basu S. Cardiopulmonary bypass as a cause of free radical-induced oxidative stress and enhanced blood-borne isoprostanes in humans. Free Radic Biol Med 34: 911-917, 2003.
127. Upritchard JE, Schuurman CR, Wiersma A, Tijburg LB, Coolen SA, Rijken PJ, and Wiseman SA. Spread supplemented with moderate doses of vitamin E and carotenoids reduces lipid peroxidation in healthy, non-smoking adults. Am J Clin Nutr 78: 985-992, 2003.
128. van den Berg R, van Vliet T, Broekmans WM, Cnubben NH, Vaes WH, Roza L, Haenen GR, Bast A, and van den Berg H. A vegetable/fruit concentrate with high antioxidant capacity has no effect on biomarkers of antioxidant status in male smokers. J Nutr 131: 1714-1722, 2001.
129. Vassalle C, Botto N, Andreassi MG, Berti S, and Biagini A. Evidence for enhanced 8-isoprostane plasma levels, as index of oxidative stress in vivo, in patients with coronary artery disease. Coron Artery Dis 14: 213-218, 2003.
130. Vessby J, Basu S, Mohsen R, Berne C, and Vessby B. Oxidative stress and antioxidant status in type 1 diabetes mellitus. J Intern Med 251: 69-76, 2002.
131. Voutilainen S, Morrow JD, Roberts LJ 2nd, Alfthan G, Alho H, Nyyssonen K, and Salonen JT. Enhanced in vivo lipid peroxidation at elevated plasma total homocysteine levels. Arterioscler Thromb Vasc Biol 19: 1263-1266, 1999.
132. Wang JF, Schramm DD, Holt RR, Ensunsa JL, Fraga CG, Schmilz HH, and Keen CL. A dose-response effect from chocolate consumption on plasma epicatechin and oxidative damage. J Nutr 130: 2115S-2119S, 2000.
133. Wang Z, Ciabattoni G, Creminon C, Lawson J, Fitzgerald GA, Patrono C, and Maclouf J. Immunological characterization of urinary 8-epi-prostaglandin F2 alpha excretion in man. J Pharmacol Exp Ther 275: 94-100, 1995.
134. Wiseman H, O'Reilly JD, Adlercreutz H, Mallet AI, Bowey EA, Rowland IR, and Sanders TA. Isoflavone phytoestrogens consumed in soy decrease F(2)-isoprostane concentrations and increase resistance of low-density lipoprotein to oxidation in humans. Am J Clin Nutr 72: 395-400, 2000.